Menu

Nascent digital PCR company QuantaLife has been awarded $820,000 from the National Institutes of Health for the first year of a five-year project aimed at developing microdroplet PCR-based point-of-care tests to detect methicillin-resistant Staphylococcus aureus, according to grant information published this month by NIH.

The grant will also support a collaboration with the University of Mississippi Medical Center to help further develop and clinically evaluate the tests, according to its abstract.

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.